MiMedx Group, Inc.

MDXG03 Dec 2024
Healthcare
$9.26
+0.01 (+1.41%)
Lowest Today
$9.16
Highest Today
$9.43
Today’s Open
$9.26
Prev. Close
$9.25
52 Week High
$9.64
52 Week Low
$5.47
To Invest in MiMedx Group, Inc.

MiMedx Group, Inc.

Healthcare
MDXG03 Dec 2024
+0.01 (+1.41%)
1M
3M
6M
1Y
5Y
Low
$9.16
Day’s Range
High
$9.42
9.16
52 Week Low
$5.47
52-Week Range
52 Week High
$9.64
5.47
1 Day
-
1 Week
+1.75%
1 month return
+62.45%
3 month return
+35.28%
6 month return
+29.87%
1 Year return
+19.17%
3 Years return
+32.85%
5 Years return
-
10 Years return
-
Institutional Holdings
Essex Woodlands Health Ventures
19.19
BlackRock Inc
6.34
Trigran Investments Inc
5.23
Vanguard Group Inc
4.74
Paradigm Capital Management, Inc.
2.84
State Street Corp
2.7
Vanguard Total Stock Mkt Idx Inv
2.48

Market Status

Fundamentals
Market Cap
1385.7 mln
PB Ratio
7.66
PE Ratio
16.54
Enterprise Value
1315.92 mln
Total Assets
239.05 mln
Volume

Company Financials

Fund house & investment objective

Company Information
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.
Organisation
MiMedx Group, Inc.
Employees
895
Industry
Biotechnology
CEO
Mr. Joseph H. Capper
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities